2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsneoplasmRecruitingPhase 2 / Phase 32026-09-18NCT03435796
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial DiseaseMuscle Weakness, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular diseaseRecruitingPhase 22026-06-26NCT05650229